About
Medherant develops a proprietary transdermal patch technology platform for drug delivery, focusing on therapies for women's health such as a testosterone patch for treating Hypoactive Sexual Desire Disorder in postmenopausal women.
Explore Medherant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.